United States Meningococcal Polysaccharide Vaccine Market Report 2016

November 2016 | 106 pages | ID: UA3CA0246B2EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Meningococcal Polysaccharide Vaccine

Revenue, means the sales value of Meningococcal Polysaccharide Vaccine

This report studies sales (consumption) of Meningococcal Polysaccharide Vaccine in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Sanofi-Pasteur
• Hualan Biological Engineering
• Zhejiang Tianyuan Bio-Pharmaceutical
• Walvax Biotechnology

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Meningococcal Polysaccharide Vaccine in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Meningococcal Polysaccharide Vaccine Market Report 2016

1 MENINGOCOCCAL POLYSACCHARIDE VACCINE OVERVIEW

1.1 Product Overview and Scope of Meningococcal Polysaccharide Vaccine
1.2 Classification of Meningococcal Polysaccharide Vaccine
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Meningococcal Polysaccharide Vaccine
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Meningococcal Polysaccharide Vaccine (2011-2021)
  1.4.1 United States Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2011-2021)
  1.4.2 United States Meningococcal Polysaccharide Vaccine Revenue and Growth Rate (2011-2021)

2 UNITED STATES MENINGOCOCCAL POLYSACCHARIDE VACCINE COMPETITION BY MANUFACTURERS

2.1 United States Meningococcal Polysaccharide Vaccine Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Meningococcal Polysaccharide Vaccine Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Meningococcal Polysaccharide Vaccine Average Price by Manufactures (2015 and 2016)
2.4 Meningococcal Polysaccharide Vaccine Market Competitive Situation and Trends
  2.4.1 Meningococcal Polysaccharide Vaccine Market Concentration Rate
  2.4.2 Meningococcal Polysaccharide Vaccine Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES MENINGOCOCCAL POLYSACCHARIDE VACCINE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Meningococcal Polysaccharide Vaccine Sales and Market Share by Type (2011-2016)
3.2 United States Meningococcal Polysaccharide Vaccine Revenue and Market Share by Type (2011-2016)
3.3 United States Meningococcal Polysaccharide Vaccine Price by Type (2011-2016)
3.4 United States Meningococcal Polysaccharide Vaccine Sales Growth Rate by Type (2011-2016)

4 UNITED STATES MENINGOCOCCAL POLYSACCHARIDE VACCINE SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Meningococcal Polysaccharide Vaccine Sales and Market Share by Application (2011-2016)
4.2 United States Meningococcal Polysaccharide Vaccine Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES MENINGOCOCCAL POLYSACCHARIDE VACCINE MANUFACTURERS PROFILES/ANALYSIS

5.1 Sanofi-Pasteur
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Meningococcal Polysaccharide Vaccine Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Sanofi-Pasteur Meningococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Hualan Biological Engineering
  5.2.2 Meningococcal Polysaccharide Vaccine Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Hualan Biological Engineering Meningococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Zhejiang Tianyuan Bio-Pharmaceutical
  5.3.2 Meningococcal Polysaccharide Vaccine Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Zhejiang Tianyuan Bio-Pharmaceutical Meningococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Walvax Biotechnology
  5.4.2 Meningococcal Polysaccharide Vaccine Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Walvax Biotechnology Meningococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview

6 MENINGOCOCCAL POLYSACCHARIDE VACCINE MANUFACTURING COST ANALYSIS

6.1 Meningococcal Polysaccharide Vaccine Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Meningococcal Polysaccharide Vaccine

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Meningococcal Polysaccharide Vaccine Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Meningococcal Polysaccharide Vaccine Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES MENINGOCOCCAL POLYSACCHARIDE VACCINE MARKET FORECAST (2016-2021)

10.1 United States Meningococcal Polysaccharide Vaccine Sales, Revenue Forecast (2016-2021)
10.2 United States Meningococcal Polysaccharide Vaccine Sales Forecast by Type (2016-2021)
10.3 United States Meningococcal Polysaccharide Vaccine Sales Forecast by Application (2016-2021)
10.4 Meningococcal Polysaccharide Vaccine Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Meningococcal Polysaccharide Vaccine
Table Classification of Meningococcal Polysaccharide Vaccine
Figure United States Sales Market Share of Meningococcal Polysaccharide Vaccine by Type in 2015
Table Application of Meningococcal Polysaccharide Vaccine
Figure United States Sales Market Share of Meningococcal Polysaccharide Vaccine by Application in 2015
Figure United States Meningococcal Polysaccharide Vaccine Sales and Growth Rate (2011-2021)
Figure United States Meningococcal Polysaccharide Vaccine Revenue and Growth Rate (2011-2021)
Table United States Meningococcal Polysaccharide Vaccine Sales of Key Manufacturers (2015 and 2016)
Table United States Meningococcal Polysaccharide Vaccine Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Meningococcal Polysaccharide Vaccine Sales Share by Manufacturers
Figure 2016 Meningococcal Polysaccharide Vaccine Sales Share by Manufacturers
Table United States Meningococcal Polysaccharide Vaccine Revenue by Manufacturers (2015 and 2016)
Table United States Meningococcal Polysaccharide Vaccine Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Meningococcal Polysaccharide Vaccine Revenue Share by Manufacturers
Table 2016 United States Meningococcal Polysaccharide Vaccine Revenue Share by Manufacturers
Table United States Market Meningococcal Polysaccharide Vaccine Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Meningococcal Polysaccharide Vaccine Average Price of Key Manufacturers in 2015
Figure Meningococcal Polysaccharide Vaccine Market Share of Top 3 Manufacturers
Figure Meningococcal Polysaccharide Vaccine Market Share of Top 5 Manufacturers
Table United States Meningococcal Polysaccharide Vaccine Sales by Type (2011-2016)
Table United States Meningococcal Polysaccharide Vaccine Sales Share by Type (2011-2016)
Figure United States Meningococcal Polysaccharide Vaccine Sales Market Share by Type in 2015
Table United States Meningococcal Polysaccharide Vaccine Revenue and Market Share by Type (2011-2016)
Table United States Meningococcal Polysaccharide Vaccine Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Meningococcal Polysaccharide Vaccine by Type (2011-2016)
Table United States Meningococcal Polysaccharide Vaccine Price by Type (2011-2016)
Figure United States Meningococcal Polysaccharide Vaccine Sales Growth Rate by Type (2011-2016)
Table United States Meningococcal Polysaccharide Vaccine Sales by Application (2011-2016)
Table United States Meningococcal Polysaccharide Vaccine Sales Market Share by Application (2011-2016)
Figure United States Meningococcal Polysaccharide Vaccine Sales Market Share by Application in 2015
Table United States Meningococcal Polysaccharide Vaccine Sales Growth Rate by Application (2011-2016)
Figure United States Meningococcal Polysaccharide Vaccine Sales Growth Rate by Application (2011-2016)
Table Sanofi-Pasteur Basic Information List
Table Sanofi-Pasteur Meningococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Sanofi-Pasteur Meningococcal Polysaccharide Vaccine Sales Market Share (2011-2016)
Table Hualan Biological Engineering Basic Information List
Table Hualan Biological Engineering Meningococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Hualan Biological Engineering Meningococcal Polysaccharide Vaccine Sales Market Share (2011-2016)
Table Zhejiang Tianyuan Bio-Pharmaceutical Basic Information List
Table Zhejiang Tianyuan Bio-Pharmaceutical Meningococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Zhejiang Tianyuan Bio-Pharmaceutical Meningococcal Polysaccharide Vaccine Sales Market Share (2011-2016)
Table Walvax Biotechnology Basic Information List
Table Walvax Biotechnology Meningococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Walvax Biotechnology Meningococcal Polysaccharide Vaccine Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Meningococcal Polysaccharide Vaccine
Figure Manufacturing Process Analysis of Meningococcal Polysaccharide Vaccine
Figure Meningococcal Polysaccharide Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Meningococcal Polysaccharide Vaccine Major Manufacturers in 2015
Table Major Buyers of Meningococcal Polysaccharide Vaccine
Table Distributors/Traders List
Figure United States Meningococcal Polysaccharide Vaccine Production and Growth Rate Forecast (2016-2021)
Figure United States Meningococcal Polysaccharide Vaccine Revenue and Growth Rate Forecast (2016-2021)
Table United States Meningococcal Polysaccharide Vaccine Production Forecast by Type (2016-2021)
Table United States Meningococcal Polysaccharide Vaccine Consumption Forecast by Application (2016-2021)